Literature DB >> 15782618

[Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10].

Nobuyuki Harada1, Kazue Higuchi, Yukie Sekiya, Jim Rothel, Takashi Kitoh, Toru Mori.   

Abstract

PURPOSES: To determine the optimum cut-off level of a newly developed method for diagnosing tuberculosis infection based on whole-blood interferon-gamma measurement, and to study the basic characteristics of the method. STUDY
SUBJECTS: 1) A total of 220 young, healthy individuals having no apparent exposure to tuberculosis infection, most of whom have had a vaccination with BCG vaccine. 2) One hundred eighteen tuberculosis patients who were diagnosed by positive Mycobacterium tuberculosis on culture. 3) A group of 75 youngsters exposed to an infectious tuberculosis patient and who showed a strong tuberculin reaction (with erythema diameter of 30 mm or more).
METHOD: Whole-blood specimens of donors were stimulated with antigens, i.e., ESAT-6 and CFP-10, and then cultured. Plasma concentrations of interferon-gamma discharged were then determined with QuantiFERON-CMI. Correlation between interferon-gamma concentrations in response to ESAT-6 and CFP-10, and their correlation with Mantoux test results were analyzed for various categories of donors. The Receiver Operating Characteristics analysis was performed considering the loss due to misclassification. [ RESULTS AND DISCUSSION: The optimum cut-off level was determined as 0.35 IU/ml for both ESAT-6 and CFP-10. This gave the test a sensitivity of 89.0% and specificity of 98.1% in detecting tuberculosis infection. The correlation of interferon-gamma response with tuberculin tests among BCG-vaccinated individuals was low, which suggested that the test was not influenced by previous BCG vaccination. The low correlation between ESAT-6 and CFP-10 tests suggested that the simultaneous use of the two tests was beneficial. As in the case of clinical tests in general, the cut-off should be set at a lower level when the test is applied to high prevalence situation and vice versa.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15782618

Source DB:  PubMed          Journal:  Kekkaku        ISSN: 0022-9776


  10 in total

1.  Comparison of performance in two diagnostic methods for tuberculosis infection.

Authors:  Kazue Higuchi; Yoshiko Kawabe; Satoshi Mitarai; Takashi Yoshiyama; Nobuyuki Harada; Toru Mori
Journal:  Med Microbiol Immunol       Date:  2008-11-26       Impact factor: 3.402

2.  Performance of a Whole-Blood Interferon-Gamma Release Assay with Mycobacterium RD1-Specific Antigens among HIV-Infected Persons.

Authors:  Akira Fujita; Atsushi Ajisawa; Nobuyuki Harada; Kazue Higuchi; Toru Mori
Journal:  Clin Dev Immunol       Date:  2010-08-10

3.  T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India.

Authors:  M Pai; R Joshi; S Dogra; A A Zwerling; D Gajalakshmi; K Goswami; M V R Reddy; A Kalantri; P C Hill; D Menzies; P C Hopewell
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

4.  Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?

Authors:  Delia Goletti; Alamelu Raja; Basirudeen Syed Ahamed Kabeer; Camilla Rodrigues; Archana Sodha; Stefania Carrara; Guy Vernet; Christophe Longuet; Giuseppe Ippolito; Satheesh Thangaraj; Marc Leportier; Enrico Girardi; Philippe Henri Lagrange
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

5.  Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia.

Authors:  Mengistu Legesse; Gobena Ameni; Gezahegne Mamo; Girmay Medhin; Gunnar Bjune; Fekadu Abebe
Journal:  BMC Infect Dis       Date:  2010-12-17       Impact factor: 3.090

6.  Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.

Authors:  Jia-Ni Xiao; Yanqing Xiong; Yingying Chen; Yang-Jiong Xiao; Ping Ji; Yong Li; Shu-Jun Wang; Guo-Ping Zhao; Qi-Jian Cheng; Shui-Hua Lu; Ying Wang
Journal:  Front Cell Infect Microbiol       Date:  2017-11-30       Impact factor: 5.293

7.  The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis.

Authors:  Martine G Aabye; Pernille Ravn; George PrayGod; Kidola Jeremiah; Apolinary Mugomela; Maria Jepsen; Daniel Faurholt; Nyagosya Range; Henrik Friis; John Changalucha; Aase B Andersen
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

8.  Diagnostic value of ex vivo pleural fluid interferon-gamma versus adapted whole-blood quantiferon-TB gold in tube assays in tuberculous pleural effusion.

Authors:  Eman N Eldin; Asmaa Omar; Mahmoud Khairy; Adel H M Mekawy; Maha K Ghanem
Journal:  Ann Thorac Med       Date:  2012-10       Impact factor: 2.219

9.  Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals.

Authors:  Basirudeen Syed Ahamed Kabeer; Rajasekaran Sikhamani; Sowmya Swaminathan; Venkatesan Perumal; Paulkumaran Paramasivam; Alamelu Raja
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

10.  The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis.

Authors:  Edward Raby; Maureen Moyo; Akash Devendra; Joseph Banda; Petra De Haas; Helen Ayles; Peter Godfrey-Faussett
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.